Endogenous intact PTH is suppressed during Teriparatide (rhPTH 1-34) administration in postmenopausal women with established osteoporosis.
Τίτλος | Endogenous intact PTH is suppressed during Teriparatide (rhPTH 1-34) administration in postmenopausal women with established osteoporosis. |
Publication Type | Journal Article |
Year of Publication | 2008 |
Authors | Anastasilakis, A. D., Polyzos S. A., Goulis D. G., Slavakis A., Efstathiadou Z., Kita M., Koukoulis G., & Avramidis A. |
Journal | Endocr J |
Volume | 55 |
Issue | 3 |
Pagination | 613-6 |
Date Published | 2008 Jul |
ISSN | 1348-4540 |
Λέξεις κλειδιά | Aged, Alkaline Phosphatase, Bone Density, Bone Density Conservation Agents, Calcium, Female, Follow-Up Studies, Humans, Osteoporosis, Postmenopausal, Parathyroid Hormone, Phosphorus, Teriparatide |
Abstract | INTRODUCTION: Teriparatide (recombinant human PTH 1-34/TPTD) is an osteoanabolic agent available for osteoporosis treatment. The aim of this prospective trial was to evaluate the acute and chronic effects of TPTD in endogenous intact PTH (iPTH) levels in postmenopausal women with established osteoporosis. |
DOI | 10.1507/endocrj.k07e-123 |
Alternate Journal | Endocr. J. |
PubMed ID | 18520104 |